Kamal Adawi

CFO

Chief Accounting Officer

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

Affiliation history

Recorded current and former roles; source labels appear when available.

Recorded roles and earnings-call appearances connecting this person to public companies.

XGN

Current role

CFO

9 calls Latest call 2024-05-13

FATE

Current role

CFO, Chief Accounting Officer

2025-10-20–present

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2025	Fate Therapeutics Inc (FATE)	M.S., MBA Chief Financial Officer and Treasurer	$99,000	—	$115,500	$456,000	$39,600	$4,700	$714,800
2024	Exagen Inc. (XGN)	Former Chief Financial Officer and Corporate Secretary	$253,684	—	$151,500	—	—	$385,106	$790,290
2023	Exagen Inc. (XGN)	Former Chief Financial Officer and Corporate Secretary	$406,477	$35,083	$239,000	—	$221,327	$13,200	$915,087
2022	Exagen Inc. (XGN)	Chief Financial Officer and Corporate Secretary	$398,507	$72,573	$556,895	—	—	$12,200	$1,040,175
2021	Exagen Inc. (XGN)	Chief Financial Officer and Corporate Secretary	$406,367	—	$682,500	$121,436	$194,554	$8,700	$1,413,557
2020	Exagen Inc. (XGN)	Chief Financial Officer and Corporate Secretary	$381,170	—	—	$590,237	$230,580	$8,550	$1,210,537
2019	Exagen Inc. (XGN)	Chief Financial Officer and Corporate Secretary	$278,110	$28,679	—	$168,831	$40,846	$8,400	$524,866
2018	Exagen Inc. (XGN)	Chief Financial Officer and Corporate Secretary	$271,039	$61,088	—	$13,910	—	$8,250	$354,287

Earnings-call appearances and filed executive appointments or departures, newest first.